Marlborough is ideally located along the Massachusetts ‘Innovation Corridor’—midway between Cambridge and Worcester, with enviable highway access to I-90, I-290 and I-495—which makes it a perfect platform for invention and collaboration. More than 40 life sciences companies, including Cytiva, Boston Scientific, Quest Diagnostics, Hologic, and Sunovion, have already discovered how convenient and economical a Marlborough location is for their operations. Many of them chose Marlborough because:
- It is rated a Platinum BioReady™ Community by the Massachusetts Biotechnology Council (MassBio), putting it among the state’s top 7%
- It is only a short driving distance from the major teaching hospitals and research facilities that support the biotech clusters in Cambridge and Worcester
- It is a convenient commute for the highly qualified intellectual talent pool and skilled labor forces in eastern and central Massachusetts, as well as the surrounding New England states
- It has an existing inventory of quality and affordable laboratory and office space
- Its local government creates a favorable environment that attracts, nurtures and supports biotech businesses
As Marlborough’s economic development arm, Marlborough Economic Development Corporation is a catalyst for the city’s rising regional life sciences and biotechnology hub status. Through the implementation of its Economic Development Master Plan, MEDC continues to strive towards attracting and nurturing quality companies that are innovative leaders in their field and can play a significant role in the future development of Marlborough as a world-class biotech cluster.
Due to its strong and growing commitment to the life sciences industry, Marlborough is rated a Platinum BioReady™ Community by the Massachusetts Biotechnology Council (MassBio). This puts the city among the most favorable biotech destinations in the state–just 7% of Massachusetts communities have achieved “Platinum” status.
In 2013, MassBio’s President and CEO Robert Coughling went a step further, when he hailed Marlborough as a “key biotechnology hub in the Commonwealth of Massachusetts.” That’s because more than 30 life sciences companies already call this city home, and that number is growing every year. Since 2014 alone, Marlborough has welcomed the new U.S. headquarters of Cytiva, the global headquarters of medical devices giant Boston Scientific and digital imaging pioneer Hologic, and the regional “Hub Lab” of testing services leader Quest Diagnostics.
- Allow biotech laboratory and manufacturing uses by right
- Identify buildings / land sites for biotechnology uses in municipal plans
- Convene site plan review meetings to provide an overview of the local approvals process for significant commercial and industrial projects
- Have land sites / buildings included in MassEcon’s BioSites inventory
- Have pre-permitted sites / buildings for biotechnology laboratory or manufacturing use
- Have existing buildings where biotech laboratory or manufacturing activities are taking place
- The municipality’s Board of Health has adopted the National Institutes of Health guidelines on rDNA activity as part of its regulations
- The municipality includes a building or buildings that are already permitted for biotech uses and have 20,000 square feet or more of available space for biotech uses
- The municipality has a shovel-ready pre-permitted land site with completed MEPA review and municipal water and sewer capacity to meet additional demand